Stand-Alone Scientific Symposium Sponsored by MSD
Looking Toward the Future:
The Latest Options for the Treatment of Patients With Type 2 Diabetes

Your Invitation to a Live Webcast

WEBCAST TRANSMITTED LIVE ON

Saturday, 8 December 2018, 09:00 (CET) from Frankfurt, Germany

Webcast:To View From Your Home or Office, Register at:

www.msddecemberdiabetes2018.com

A replay of the live webcast will begin at 19:00 on 8 December 2018 and will be available for 24 hours.

This program is not intended for health care professionals who practice in, are licensed to practice in, or reside in the U.S., its territories, or Puerto Rico.

Co-Chairs: Juris Meier (Germany), Bernard Zinman (Canada)

agenda
09:00 – 09:05 Welcome and Introduction Co-Chairs
09:05 – 09:30 A Look Back and a Look Forward: The Future of Treatment for Patients With Type 2 Diabetes Pablo Aschner
09:30 – 09:35 Q&A
09:35 – 10:00 Ertugliflozin – A Newly Emerging SGLT2 Inhibitor for Patients With Type 2 Diabetes Samuel Dagogo-Jack
10:00 – 10:05 Q&A
10:05 – 10:30 Combination Therapy Treatment – Why It Makes Clinical Sense for Patients With Type 2 Diabetes Bernard Zinman
10:30 – 10:35 Q&A
10:35 – 11:05 Break
11:05 – 11:30 DPP-4 Inhibitors and SGLT2 Inhibitors – A Mechanism for the Future? David Cherney
11:30 – 11:35 Q&A
11:35 – 12:35 Cross-Disciplinary Clinical Considerations: An Interactive Patient Case Faculty
12:35 – 12:45 Closing Remarks Co-Chairs